Anocca gains European authorisation for Phase I/II trial of pancreatic cancer drug
The trial’s first phase will begin in university hospitals across the Netherlands, Denmark, Germany and Sweden.
Anocca Announces Authorisation of Clinical Trial Application to Start First In-Human Trial in Advanced Pancreatic Cancer
CTA approval marks Anocca’s transition to a clinical-stage companyFirst-in-human VIDAR-1 trial begins with the deployment of ...
University of Geneva3d
Pr Federica Benvenuti 11 April
Type 1 dendritic cells are key to initiate and maintain anti-tumoral T-cell responses in diverse tumour tissues. Our lab focuses on tissue-specific properties of cDC1 in lung tumours, focusing on the ...
Medullary Carcinoma: Insights into Thyroid and Colon Subtypes
While both are called medullary carcinoma, these cancers differ in many ways: ...
Le Lézard7d
Alterome Doses First Patient in Phase 1 Study of ALTA3263, a Novel Pan-KRAS Dual ON/OFF Inhibitor, in Advanced Solid Tumors
Alterome Therapeutics, Inc., a clinical-stage biopharmaceutical company pioneering the development of next-generation, small molecule targeted therapies for the treatment of cancer, today announced ...
Silexion Therapeutics Reports Groundbreaking Positive Initial Data from Systemic Administration of SIL204 in Orthotopic Pancreatic Cancer Models
Initial validation using orthotopic models: SIL204 administered subcutaneously (systemically) showed significant efficacy in ...
The Lancet17d
Assessing the oncogenic risk: the long-term safety of autologous chimeric antigen receptor T cells
aCenter for Cellular Immunotherapies, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA bDepartment of Pathology and Laboratory Medicine, University of Pennsylvania ...
Medical Xpress27d
Discovery reveals key protein that helps squamous cell carcinoma resist ferroptosis
Their findings were published in the journal Oncogene. Ferroptosis is a unique type of cell death triggered by the accumulation of iron and the oxidation of lipids in the cell membrane.